Noncovalent Peptide Stapling Using Alpha-Methyl-l-Phenylalanine for α-Helical Peptidomimetics
- J Am Chem Soc. 2023 Sep 20;145(37):20242-20247. doi: 10.1021/jacs.3c02743.
- 1. The Florey, The University of Melbourne, Parkville, VIC 3052, Australia.
- 2. Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC 3052, Australia.
- 3. Australian Nuclear Science Technology Organisation, The Australian Synchrotron, Clayton, VIC 3168, Australia.
- 4. Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia.
- 5. Predepartmental Unit of Medicine, Faculty of Health Sciences, Universitat Jaume I, Avenida de Vicent Sos Baynat, s/n, 12071 Castelló de La Plana, Spain.
- 6. Department of Anatomy and Physiology, The University of Melbourne, Parkville, VIC 3052, Australia.
- 7. School of Biomedical Sciences, The University of Queensland, St Lucia, QLD 4072, Australia.
- 8. Bio21 Molecular Science and Biotechnology, The University of Melbourne, Parkville, VIC 3052, Australia.
- 9. School of Chemistry, The University of Melbourne, Parkville, VIC 3052, Australia.
Peptides and peptidomimetics are attractive drug candidates because of their high target specificity and low-toxicity profiles. Developing peptidomimetics using hydrocarbon (HC)-stapling or Other stapling strategies has gained momentum because of their high stability and resistance to proteases; however, they have limitations. Here, we take advantage of the α-methyl group and an aromatic phenyl ring in a unique unnatural amino acid, α-methyl-l-phenylalanine (αF), and propose a novel, noncovalent stapling strategy to stabilize peptides. We utilized this strategy to create an α-helical B-chain mimetic of a complex insulin-like peptide, human relaxin-3 (H3 relaxin). Our comprehensive data set (in vitro, ex vivo, and in vivo) confirmed that the new high-yielding B-chain mimetic, H3B10-27(13/17αF), is remarkably stable in serum and fully mimics the biological function of H3 relaxin. H3B10-27(13/17αF) is an excellent scaffold for further development as a drug lead and an important tool to decipher the physiological functions of the neuropeptide G protein-coupled receptor, RXFP3.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: RXFP ReceptorResearch Areas: Others